Pages that link to "Q48093388"

The following pages link to A resurging boom in new drugs for epilepsy and brain disorders. (Q48093388):

Displaying 11 items.

• Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy. (Q47967839) (← links)
• 3β-Methyl-Neurosteroid Analogs Are Preferential Positive Allosteric Modulators and Direct Activators of Extrasynaptic δ-Subunit γ-Aminobutyric Acid Type A Receptors in the Hippocampus Dentate Gyrus Subfield. (Q54981484) (← links)
• Differential Gene Expression Profile Induced by Valproic Acid (VPA) in Pediatric Epileptic Patients (Q57583359) (← links)
• Benzodiazepine-refractory status epilepticus, neuroinflammation, and interneuron neurodegeneration after acute organophosphate intoxication (Q88869898) (← links)
• Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa (Q90319280) (← links)
• Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089) (Q91775687) (← links)
• Genetic variations associated with pharmacoresistant epilepsy (Review) (Q92142648) (← links)
• Design, synthesis and biological evaluation of N-substituted α-hydroxyimides and 1,2,3-oxathiazolidine-4-one-2,2-dioxides with anticonvulsant activity (Q92610534) (← links)
• Inflammasome inhibitors: promising therapeutic approaches against cancer (Q93050768) (← links)
• Zinc reduces antiseizure activity of neurosteroids by selective blockade of extrasynaptic GABA-A receptor-mediated tonic inhibition in the hippocampus (Q93339679) (← links)
• Mechanism-based novel antidotes for organophosphate neurotoxicity (Q98779326) (← links)